丹参素对大鼠肝星状细胞NF-κB信号转导通路的影响
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:观察丹参素对白介素-1β(Iinterleukin-1β,IL-1β)刺激的肝星状细胞(hepatic stellate cell,HSC)增殖、凋亡、Ⅲ型胶原合成和分泌,以及磷酸化核因子κB抑制蛋白α(Phosphorylated Inhibitor ofκBα, p-IκBα)、核转录因子κB蛋白65(Nuclear transcription factor-kappa B proteinum 65, NF-κB p65)的影响,探讨丹参素抗肝纤维化的分子机制。
     方法:用改良的胶原酶消化-原位循环灌流-密度梯度离心法提取HSC,α-SMA免疫细胞化学染色法鉴定分离HSC。以不同浓度的丹参素作用于IL-1β刺激的HSC,MTT法、AO/EB免疫荧光和AnnexinⅤ-FITC/PI分别检测HSC的增殖、凋亡;免疫细胞化学、ELISA法、Western Blot分别检测Ⅲ型胶原的生成、NF-κB核转位及细胞浆p-IκBα、细胞核NF-κB p65的表达。
     结果:1.原代分离的HSC细胞得率3.5×107/只鼠,纯度大于95%,存活率大于96%. 2.与对照组相比,IL-1β刺激组HSC增殖明显增加(P<0.01),凋亡率减低(P<0.05),Ⅲ型胶原的合成和分泌明显增加(P<0.01);不同浓度丹参素作用24h后HSC增殖明显减低(P<0.01),凋亡明显增加(P<0.01),以早期凋亡为主,Ⅲ型胶原的合成和分泌亦明显减少(P<0.05或P<0.01),以上作用呈浓度依赖性(P<0.05或P<0.01),且以0.25mmol/L丹参素作用为著;Western Blot结果显示IL-1β刺激组细胞浆p-IκBα、细胞核NF-κB p65蛋白表达明显增加(P<0.01),细胞浆p65表达明显减低(P<0.05),出现明显核转位,免疫细胞化学显示细胞核内p65阳性染色细胞增多浓染,提示IL-1β可以诱导HSC的NF-κB活性;不同浓度丹参素组细胞浆p-IκBα、细胞核NF-κB p65蛋白表达明显减低(P<0.05或P<0.01),上述蛋白减低作用呈浓度依赖性(P<0.05),0.25mmol/L丹参素组细胞浆p65蛋白表达明显增加(P<0.05),该组细胞核内p65阳性染色细胞数减少淡染,核转位减少,提示丹参素可以浓度依赖性地抑制HSC的IκBα的磷酸化,减少细胞核NF-κB p65表达,阻止NF-κB核转位,从而抑制NF-κB活性。
     结论:1.改良的HSC分离法能分离出高产、高纯度的HSC。原代分离的大鼠HSC经过鉴定具有活化HSC的生物学特性,是体外研究肝纤维化的理想模型。2.丹参素抑制IL-1β诱导的HSC增殖,促使HSC凋亡,减少Ⅲ型胶原的合成和分泌,同时伴随磷酸化IκBα、细胞核NF-κBp65表达和NF-κB核转位减低,其机制可能与丹参素抑制Rel/NF-κB/IκB信号通路有关。
Objectives:To investigate the effects of Danshensu on proliferation、apoptosis、synthesis and secretion of collagen tapeⅢand expression of p-IκBαand NF-κB p65 induced by IL-1βin rat hepatic stellate cells(HSCs), and to elucidate the molecular mechanisms of Danshensu against hepatic fibrosis.
     Methods:The rat HSC was isolated with improved collagenase digested in situ-liver recirculating perfusion and cultured in vitro. It was identified byα-SMA immunocytochemical stain .Then it was treated with different concentration of Danshensu. MTT colorimetric assay was used to detect proliferation of HSC. AO/EB immunoflurorescence micropy and combination Annexin-V-FITC/PI double-labelimmunofluorescence with flow cytometry were used to examine apoptosis of HSC. Synthesis and secretion of collagen tapeⅢwere detected by the quantitative immunocytochemical assay and ELISA method espectively. The amounts of cytoplasm p-IκBα、NF-κB p65 and of nuclear NF-κB p65 in HSC were determined by Western blot. Immunocytochemical stain and Western blot were used to observe nuclear translocation of NF-κB p65.
     Results: 1. The yield of HSC was about 3.5×107 per rat.The purity of HSC exceed 95%,and the survival rate of HSC exceed 96%. 2. Compared with normal control group,IL-1βcould increase proliferation of HSC (P<0.01),reduce apoptosis of HSC(P<0.05), and facilitate synthesis and secretion of collagen tapeⅢin HSC(P<0.01). After treated with different concentration of Danshensu, HSC’s proliferation prominently reduced(P<0.01) and its apoptosis increased(P<0.01), especially of early apoptosis. Danshensu could also degrade synthesis and secretion of collagen tapeⅢin HSC (P<0.05 or P<0.01). Danshensu had a concentration-
     dependent effect on avove parts (P<0.05 or P<0.01), especially in 0.25mmol/L Danshensu treated group.Western Blot results showed that IL-1βelevated amounts of cytoplasm p-IκBαand nuclear NF-κBp65(P<0.01), decreased amounts of cytoplasm p65 markedly (P<0.05), then facilitated nuclear translocation of p65. Immunocytochemical stain results signed that the number of nuclear NF-κB p65 positive HSC increased and the colour deepened. It mained that IL-1βcould induce NF-κB activation in rat HSC. Danshensu had a concentration-dependent effect on reducing amounts of cytoplasm p-IκBαand nuclear NF-κB p65(P<0.05 or P<0.01), and 0.25mmol/L Danshensu could decrease nuclear translocation of p65 markedly(P<0.05). In above group,immunocytochemical stain results showed that the number of nuclear NF-κB p65 positive HSC decreased and the colour grew pallid. Above results indicated that Danshensu could inhibit IκBαphosphorylation,reduce expresstion of nucear NF-κB p65, and prevent nuclear translocation of NF-κB,and then inhibit NF-κB activation in rat HSC.
     Conclusions: 1.Improved isolation method of HSC has the character of high productin and high purity. Primary identified and cultured rat HSC has biological character of activated HSC and it was an important experimental object to investigate liver fibrosis in vitro.2.Danshensu could inhibit the proliferation of HSC, facilitate the apoptosis of HSC, and reduce the synthesis and secretion of collagen tapeⅢ. Meanwhile, Danshensu could inhibit IκBαphosphorylation,reduce expresstion of NF-κB p65, and prevent nuclear translocation of NF-κB,and then inhibit NF-κB activation in rat HSC. So Danshensu could inhibit Rel/NF-κB/IκB signal transduction pathway .It might be the mechanism of Danshensu against hepatic fibrosis.
引文
[1] Elsharkawy AM, Oakley F, Mann DA.The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis [J]. Apoptosis.2005, 10:927-939.
    [2] Gakuhei Son, Yuji Iimuro, Ekihiro Seki, et al.Selective inactivation of NF-κB in the liver using NF-κB decoy suppresses CCl4-induced liver injury and fibrosis [J]. Am J Physiol Gastrointest Liver Physiol.2007, 293: G631–G639.
    [3] Hellerbrand C, Jobin C, Licato L.L, et al. Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells[J]. Am J Physiol Gastrointest Liver Physiol.1998; 275:269-278.
    [4] Schwabe RF, Schnabl B, Kweon YO, et al. CD40 activates NF-kappaB and c-Jun N-terminal kinase and enhances chemokine secretipn on activated human hepatic stellate cell[J].J Immunol.2001,166(11):6812-6819.
    [5] Hernundez E, Bucio L,Souza V, et al. Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of IkappaB alpha degradation in liver stellate cells. Cell Biol Toxicol. 2007 Oct 20.
    [6] Cheng Y, Ping J, Xu LM. Effects of curcumin on peroxisome proliferators- activated-receptor-gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chin Med J (Engl). 2007 May5;120(9): 794-801.
    [7]朱惠利,沈薇,陈忠勇.柳氮磺胺吡啶诱导HSC-T6肝星状细胞凋亡及其机制[J].第三军医大学学报.2008,30(1):70-75.
    [8]谭焱,吕志平,欧素能,张绪富.保肝宁对肝星状细胞中核转录因子一κB活性影响的实验研究[J].中国中西医结合杂志.2005,9月,25卷,第9期。
    [9] Kida Y, Kobayashi M, Suzuki T, Hasegawa K. Interleukin-1 stimulate cytokines, prostaglatin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1and NF-kappaB in human gingival fibroblasts. Cytokine.2005,29:159-168.
    [10]沈映君,徐秋萍,陈奇等.中药药理学[M].北京:人民卫生出版社,2000:661-670.
    [11]吴亚云,耿晓霞,程明亮.丹芍化纤方对体外大鼠肝细胞增生、Caspase-3mRNA及白蛋白合成的影响[J].世界华人消化杂志.2005,3,13(6):781-783.
    [12]李欣,戴立里,张文利等.四种中药单体的抗肝纤维化作用及机制及机制研究[J].中华肝脏病杂志.2008,16(3):193~197.
    [13]郑元义,戴立里,王文兵.丹参素治疗肝纤维化及其作用机制的研究[J].中华肝病杂志.2003,11(5):288~290.
    [14]罗云,戴立里,沈鼎明等.丹参诱导大鼠肝星状细胞凋亡作用的研究[J].重庆医学.2003,12,32(12):1701-1702.
    [15] Knook DL,Seffelaar AM,de Leeuw AH.Fat-storing cell of the rat liver.Their isolation and purification[J].Exp Cell Res.l982,139:468~471
    [16]王文兵,戴立里,郑元义.改良大鼠HSC分离及性质鉴定[J].中华肝脏病杂志.2005,14(3):239~242.
    [17] Faouzi S,Le Bail B,Neaud V,et al. Myofibroblasts are responsible for collagen synthesis in the stroma of hum an hepatocellular carcinoma:an in vivo and in vitro study[J].Hepatol.1999,30:275-284
    [18] Jiang SQ, Zhang XL,Liu L. Salvia miltiorrhiza monomer IH764-3 induces hydrogen dioxide stimulated hepatic stellate cell apoptosis by down regulating focal adhensin kinase[J]. Chin J Pathophysiol.2003,19(1):18-21.
    [19] HSU YC.Lin YL,Chiu YT,et a1. Antifibrotic efects of Salviamiltiorrhiza on dimethylnitro-amine-intoxicated rats.J Biomed Sci.2005,2:185-195.
    [20] Liu P, Hu YY, Liu C, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B[J]. World J Gastroenterol .2002,8: 679–685.
    [21] Wang HN,Hu YY,Hong JH,et al. Effects of salvianolic-acid B on proliferation and TGF-β1 signal transduction of hepatic stellate cells[J]. Chin J Hepatol. 2002,Oct,10(5):382-394.
    [22]王建.益气活血方药抗大鼠肝纤维化作用机理的实验研究[D].北京:北京中医药大学,2002年.
    [23] Bours V., Bonizzi G., Bentires-Alj M., Bureau F., Piette J., et al. NF-κB activation in response to toxical and therapeutical agents: role in inflammation and cancertreatment .Toxicology.2000,153, 27-38.
    [24] Lang A, Schoonhonen R, Tuvia S,et al. Nuclear factor kappaB in proliferation, activation and apoptoisis in rat hepatic stellate cells[J].Hepatol.2000, Jul,33(1): 49-58.
    [25]张岁,崔东来.核因子-κB亚单位p65短发夹状干扰RNA对肝星状细胞凋亡的影响[D].河北:河北医科大学,2008年.
    [26] Anan A., Baskin-Bey E.S., Bronk S.F,et al.Proteasome inhibition induces hepatic stellate cell apoptosis[J].Hepatolology.2006,43(2):335-344.
    [27] Hellerbrand C, Jobin C, Iimuro Y, et al. Inhibition of NFkB in Activated Rat Hepatic Stellate Cells by Proteasome Inhibitors and an IkB Super-Repressor [J] .Hepatology. 1998, 27 (5): 1285-1295.
    [28] Pei Luo,Zhenghuai Tan, Zhifeng Zhang. Inhibitory Effects of Salvianolic Acid B on the High Glucose-Induced Mesangial Proliferation via NF-κB-Dependent Pathway. Biol. Pharm. Bull.2008,31(7):1381-1386.
    [29] Sun Lianping, Zheng Zhi. The effects of sodium tanshinoneⅡA sulfonate on activation of NF-κB on hypertrophic myocardial cells. Practical Geriatrics.2004,18(1):25-27.
    [30] Jang SI, Kim HJ, Kim YJ,et al. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways[J].Eur.J Pharmacol. 2006 Aug 7,542(1-3):1-7.
    [31]董静,罗桂林,苗维纳,刘绍唐.丹参对实验性肺纤维化小鼠病理变化和核因子-κB表达的影响[J].中国药理学通报.2003,19:1428-1431.
    [32]黄富春,范钰,李华.丹参对大鼠肝星状细胞核因子-κB活性和肿瘤坏死因子-α影响[J].医药导报.2005,2,24(2):103-105.
    [1] Gabele E., Brenner D.A., and Rippe R.A.. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front. Biosci.2003,8:D69-D77
    [2] Gaca MD. Regulation of heptic stellate cell proliferation and collagen syntesis by proteinase-activated[J]. J Hepatol.2002; 36:362-369.
    [3] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences[J].Cell.1986,46(5):705-716
    [4] Lorraine I, Mckay and John A, Cidlowski. Molecular Control of Immune/Inflammatory Response: Ineractions Between Nuclear Factor-kB and Steroid Rcepator-Signaling Pathway. Endocrine Reviews.
    [5] Baldwin AS Jr. The NF-kappa B and Ikappa B proteins: new discoveries andinsights [J]. Annu Rev Immunol .1996,14:649-683.
    [6] Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death[J]. Science.1996,274(5288):782-784.
    [7] Chen Y, Vallee S, Wu J, et al. Inhibition of NF-kappaB activity by IkappaB beta in association with kappaB-Ras[J].Mol Cell Biol.2004,24(7):3048-3056
    [8] Woronnicz JD, Gao X, Cao Z, et al. IkappaB kinase-beta: NF-kappaB activation and compalex formation with IkappaB kinase-alpaha and NIK[J]. Science.1997,278 (5339):866-869.
    [9] Ghosh S,M Karin. Missing pieces in the NF-kappaB puzzle.Cell.2002, 109:S81– S96.
    [10] Aggarwal BB, Takada Y, Shishodia S, et al. Nuclear transcription fator NF-kappaB: role in biology and medicine[J].Indian J Exp Biol.2004,42(4):341-353.
    [11] Lee KS, Buck M, Houglun K. Activation of hepatic stellate cells by TGF-alpha and collagen type I is mediated by oxidative stress through c-myb espression[J]. J Clin Invest.1995, 96(5):2461-2468.
    [12] Hellerbrand C, Jobin C, Licato LL, et al. Cytokines induce NF-kappaB in activated but mot in quiescent rat hepatic stellate cells[J]. Am J Physiol.1998,275:269-278.
    [13] Hellerbrand C, Jobin C, Iimuro Y,et al. Inhibition of NF-kappaB in activated tat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor[J]. Hepatology.1998 ,May 27(5):1285-1295.
    [14] Elsharkawy AM, Wright MC, Hay RT, et al. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like fators and prolonged changes in the expression of IkappaB family proteins[J]. Hepatology.1999,30(3):761-9.
    [15]赵宗豪,梅俏,吴军等.NF-kB与大鼠肝纤维化关系地实验研究[J].安徽医学.2003年第24卷第5期。
    [16] Schwabe RF, Schnabl B, Kweon YO, et al. CD40 activates NF-kappaB and c-Jun N-terminal kinase and enhances chemokine secretipn on activated human hepaticstellate cell[J]. J Immunol.2001,166(11):6812-9.
    [17] Lee KS, Lee sj, Park HJ, et al. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med J. 2001 Feb, 42(1):1-8.
    [18] Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration[J]. Am J Physiol Gastrointest Liver Physiol.2003 Nov, 285(5):G949-58.
    [19] Chen A,Zhang L.The antioxidant -EGCG inhibits rat HSC proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of PDGFR[J]. J Biol Chem. 2003 Jun 27,278(26):23381-23389.
    [20] Chen A,Zhang L , Xu J, et al. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression[J]. Biochem J. 2002 Dec 15,368(3):695-704.
    [21] Hernundez E, Bucio L,Souza V, et al. Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells. Cell Biol Toxicol. 2007 Oct 20.
    [22] Chen A, Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kB and ERK signalling[J].Br J Pharmacol online.2007 Oct 29.
    [23] Lv P, Luo HS, Zhou XP, et al. Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappaB/inhibitor of nuclear factor-kappaB pathway. Arch Med Res. 2007 Jan,38(1):15-27.
    [24] Li X, Meng Y, Wu P, et al. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.Regul Pept.2007 Jan 10,138(1):15-25.
    [25] Paik YH,Schwabe RF,Bataller R, et al.Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells[J]. Hepatology,2003 May,37(5):1043-1055.
    [26] Muhlbauer M, Weiss TS, Thasler WE, et al. LPS-mediated NF-kappaB activation varies between activated human hepatic stellate cells different donors. BiochemBiophys Res Commun. 2004 Dec3,325(1):191-197.
    [27] Kang KH , Lee KH ,Kim MY , et al. Ras regulation of NF-kappa B and apoptosis. Methods Enzymol .2001 ,333:73~87.
    [28] Lang A, Schoonhoven R, Tuvia S, et al. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol.2000; 33(1):49-58.
    [29] Montiel-Dnarte C, Ansorena E, Lopez-Zabalza MJ, et al. Role of reactive oxygen species,glut- athione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.Biochem Pharmacol. 2004 Mar 15, 67(6):1025-1033.
    [30] Saile B, Mattes N, El Armouche H, et al. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells[J]. Eur J Cell Biol. 2001 Aug,80(8):554-561
    [31] Oakley F, Trim N, Constandinou C, et al. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis[J]. Am J Pathol.2003,163:1849-1858.
    [32] Saile B, DeRocco P , Dudas J , et al. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells ( HSC) but DNA synthesis and proliferation in rat liver myofibroblasts( rMF) . Lab Invest. 2004 ,84 : 1037-1049.
    [33] Zhang LJ, Zheng WD, Shi MN et al. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fi brotic rat liver[J].World J Gastroenterol.2006,March 28,12(12): 1918-1923.
    [34] Park MY, Jang HD, Lee SY, et al. Fas-associated factor-1 inhibits nuclear factor-kappaB (NF- kappaB ) activity by interfering with nuclear translocation of the RelA﹙ p65 ) subunit of NF-kappaB[J].J Biol Chem. 2004 Jan 23,279(4):2544-2549.
    [35] Park MY, Moon JH, Lee KS, et al. FAF1 suppresses IkappaB kinase (IKK) activation by dis- rupting the IKK complex assembly.J Biol Chem.2007 Sep 21,282(38):27572-27577.
    [36] Aggarwal S, Ichikawa H, Takada Y, et al. Curcumin(diferuloylmethane) down-regulates expr- ession of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaB alpha kinase and Akt activation.Mol Pharmacol.2006 Jan,69(1):195-206.
    [37] Takada Y, Ichikawa H, Pataer A, et al. Genetic deletion of PKR abrogates TNF-induced activ- ation of IkappaB alpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.Oncogene.2007 Feb 22,26(8):1201-12.
    [38] Wang CY,Mayo MW,Komeluk RG,et al.NF-kB antiapoptosis:induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.Science.1998,281:1680-1683.
    [39] Marca F, Efsen E, Romanelli RG,et al. Capsase-3 mediated cleavage of the NF-kappaB Subnunit p65 at the NH2 Terminus Potentiates Naphthcpuinone Analog-induced apoptosis. J Bio Chem.2001,276:24638-24644.
    [40] Oakley F, Meso M. Iredale JP, et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.Gastroenterology. 2005 Jan,128(1):108-20.
    [41] Habens F,Srinivasan N,Oakley F,et al. Novel sulfasalazine analogues with enhanced NF-κB inhibitory and apoptosis promoting activity. Apoptosis. 2005,10: 481–491.